Effect of Asl us soos and Nawra to treat extra hair growth in women.

CLINICAL EVALUATION OF ANTIANDROGENIC ACTIVITY OF Asl us soos(Glycyrrhiza glabra linn) AND NAWRA IN WOMEN WITH HIRSUTISM:A SINGLE ARM INTERVENTIONAL STUDY. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106347

Enrollment

Registered

2026-03-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L680- Hirsutism

Interventions

Intervention1: 1.Asl-us-soos(Glycyrrhiza glabra linn.) 2.Zarneeq zard or Hartal warqi (Arsenic trisulphide) 3.Buja hua chuna(Limestone): Patients will be given powdered Asl-us-soos orally 5 gms OD for

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients within the age group 15 years to 40 year. 2.serum total or free testosterone more than 70ng/dl and less than 200ng/dl. 3.Ferriman Gallway score more than 8

Exclusion criteria

Exclusion criteria: 1.Patients below 15 years and above 40 year. 2.Pregnancy and lactation. 3.Tumors of ovary and Adrenal glands disorders. 4.Serum total testosterone more th n 200ng/dl.

Design outcomes

Primary

Measure	Time frame
1.Reduction in Ferriman Gallway score. 2.Decrease in serum Total testosterone.Timepoint: Baseline 0th day to 90th day.	—

Secondary

Measure	Time frame
1.Improvement in menstrual cycle regularity. 2.Patient Satisfaction . 3.Safety and tolerability of treatment.Timepoint: Baseline 0th day to 90th day.	—

Countries

India

Contacts

Public ContactDr Rabbab Fatima

Government Nizamia Tibbi College and General Hospital

drssntc@gmail.com9908624090

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026